. /.WORLD TRADE
ORGANIZATIONG/SPS/N/MAC/4
6 November 2001
(01-5459)
Committee on Sanitary and Phytosanitary Measures Original:  English
NOTIFICATION
1. Member to Agreement notifying:  MACAO, CHINA
If applicable, name of local government involved:           
2. Agency responsible:  Department of Health
3. Products covered (provide tariff item number(s) as specified in national schedules
deposited with the WTO; ICS numbers may be provided in addition, where
applicable).  Medicines derived from bovine materials (HC 30)  Regions or countries
likely to be affected, to the extent relevant or practicable:           
4. Title and number of pages of the notified document:  Chief Executive Decision
No. 131/2001 (1 page)
5. Description of content:  Suspension of the importation of all the medicines containing
bovine substance of which the origins are the countries with incidence of BSE
6. Objective and rationale: [     ] food safety,  [     ] animal health,  [     ] plant protection,
[ X ] protect humans from animal/plant pest or disease,
[    ] protect territory from other damage from pests           
7. An international standard, guideline or recommendation does not exist [     ].
If an international standard, guideline or recommendation exists, give the appropriate
reference and briefly identify deviations:
• Notification for enforcing the importation control of medicines derived from bovine
materials.  -  State Drug Administration (China)
• Report of a WHO consultation on medicinal and other products in relation to human
and animal transmissible spongiform encephalopathies.  -  WHO
• Recommendations for use of medicine (including vaccines) manufactured with bovine
derived materials.  -  FDA(U.S.A.)
• Note for guidance on Minimising the risk of transmitting animal Spongiform
encephalopathy agents via human and veterinary Medicinal Products. – EMEA
(European)
8. Relevant documents and language(s) in which these are available:  Macao  Special
Administrative Region Bulletin No. 27, Series I (available in Chinese and Portuguese)
9. Proposed date of adoption:  Not applicable
10. Proposed date of entry into force:  2 July 2001 (date of entry into force)G/SPS/N/MAC/4
Page 2
11. Final date for comments:  Not applicable
Agency or authority designated to handle comments:  [     ] National notification
authority, [     ] National enquiry point, or address, fax number and E-mail address (if
available) of other body:           
12. Texts available from: [     ] National notification authority, [  X ] National enquiry point
or address, fax number and E-mail address (if available) of other body:
Department of Health
Caixa Postal 3002
Macao SAR
China